Prediction of population with Alzheimer's disease in the European Union using a system dynamics model

Código QR

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model

Hana Tomaskova,1 Jitka Kuhnova,2 Richard Cimler,1,3 Ondrej Dolezal,1 Kamil Kuca3 1Faculty of Informatics and Management, 2Faculty of Science, 3Center for Basic and Applied Research (CZAV), University of Hradec Králové, Hradec Králové, Czech Republic Introd...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Alzheimer disease population modeling system dynam- ics prediction model Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/b1855791d6414ef68206c7e03b9798cb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Alzheimer's disease and its treatment costs: case study in the Czech Republic
por: Mohelska H, et al.
Publicado: (2015)

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
por: Kishi T, et al.
Publicado: (2017)

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
por: Xin-Yu Yang, et al.
Publicado: (2021)

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study
por: Shiromaru-Sugimoto A, et al.
Publicado: (2018)

Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampus–prefrontal cortex dysconnectivity
por: Sampath D, et al.
Publicado: (2017)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease
por: Giau VV, et al.
Publicado: (2018)

Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review
por: Klimova B, et al.
Publicado: (2018)

Aberrant brain-stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's disease
por: Lee JH, et al.
Publicado: (2016)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
por: Zvěřová M
Publicado: (2018)

Fine mapping of the HLA locus in Parkinson’s disease in Europeans
por: Eric Yu, et al.
Publicado: (2021)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation
por: Hui Wang, et al.
Publicado: (2021)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Hannah Walgrave, et al.
Publicado: (2021)

Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
por: Emma van Kessel, et al.
Publicado: (2021)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
por: Wallin &Aring;K, et al.
Publicado: (2011)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
por: Tran T, et al.
Publicado: (2011)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Wenjuan Rui, et al.
Publicado: (2021)

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
por: Zhou L, et al.
Publicado: (2016)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
por: Nakaaki S, et al.
Publicado: (2012)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

The Alzheimer’s disease drug development landscape
por: Pieter van Bokhoven, et al.
Publicado: (2021)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Marco J. Russo, et al.
Publicado: (2021)

Editor&#39;s choice
por: Pinder RM
Publicado: (2012)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan L, et al.
Publicado: (2020)

Nutrition Challenges of Patients with Alzheimer’s Disease and Related Dementias: A Qualitative Study from the Perspective of Caretakers in a Mental National Referral Hospital
por: Kigozi E, et al.
Publicado: (2021)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
por: Edmond Teng, et al.
Publicado: (2021)

Development and Validation of a Predictive Model for Spontaneous Hemorrhagic Transformation After Ischemic Stroke
por: Chenchen Wei, et al.
Publicado: (2021)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
por: Hinz M, et al.
Publicado: (2016)

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
por: Shi Q, et al.
Publicado: (2020)

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study
por: Fujimoto H, et al.
Publicado: (2017)